• The document is an intimation of a scheduled Analyst/Investor Meet, filed as a regulatory disclosure.
  • The event is a physical group meeting with Investors/Analysts.
  • The meeting is scheduled for 28th August 2026. A specific time was not disclosed in the provided data.
  • The stated purpose is for interaction with investors and analysts, though no specific discussion topics (e.g., results) are mentioned.
  • The relationship of this meeting to an earnings announcement (before or after) is not specified.
  • Management participants and their designations are not provided in the disclosure.
  • The availability of a presentation, earnings deck, transcript, or recording is not mentioned.
  • The disclosure does not contain any specific language indicating that no unpublished price sensitive information (UPSI) will be shared.

Additional Notes Section

  • No financial data, guidance, or strategic updates were disclosed in this announcement.
  • The document is a standalone letter of intimation; no attachments (e.g., invite, presentation deck) are mentioned as being included.
  • The company explicitly states that the provided schedule is "subject to changes" due to exigencies.